Ocko Matthew

CIK 00018360895 companiesPALO ALTO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001836089

Recent Transactions

43 trades

Sale
Rocket Lab Corp$RKLB
Common Stock
2024-11-15$18.21/sh−2,393,001→ 3,388,249 total
Sale
Rocket Lab Corp$RKLB
Common Stock
2024-11-15$18.21/sh−973,192→ 1,377,943 total
Sale
Rocket Lab Corp$RKLB
Common Stock
2024-11-14$17.73/sh−578,215→ 2,351,135 total
Sale
Rocket Lab Corp$RKLB
Common Stock
2024-11-14$17.73/sh−1,421,785→ 5,781,250 total
Disposition to Issuer
Zymergen Inc.
Common Stock
2022-10-19−2,448,901→ 0 total
Disposition to Issuer
Zymergen Inc.
Common Stock
2022-10-19−4,917,734→ 0 total
Purchase
Embark Technology, Inc.
Class A Common Stock
2022-08-30$9.64/sh+10,000→ 3,212,107 total
Purchase
Embark Technology, Inc.
Class A Common Stock
2022-08-18$11.64/sh+10,000→ 3,202,107 total
Purchase
Embark Technology, Inc.
Class A Common Stock
2022-08-16$0.84/sh+122,000→ 3,192,107 total
Other
AbCellera Biologics Inc.$ABCL
Common Shares
2021-06-18−5,000,000→ 24,105,761 total
Other
AbCellera Biologics Inc.$ABCL
Common Shares
2021-06-18+73,892→ 73,892 total
Conversion
Zymergen Inc.
Series C Preferred Stock
2021-04-26−294,401→ 0 total
Conversion
Zymergen Inc.
Series A-1 Preferred Stock
2021-04-26−2,014,506→ 0 total
Conversion
Zymergen Inc.
Common Stock
2021-04-26+294,401→ 4,917,734 total
Conversion
Zymergen Inc.
Series A Preferred Stock
2021-04-26−210,450→ 0 total
Conversion
Zymergen Inc.
Series D Preferred Stock
2021-04-26−223,945→ 0 total
Conversion
Zymergen Inc.
Common Stock
2021-04-26+223,945→ 2,448,901 total
Conversion
Zymergen Inc.
Series A Preferred Stock
2021-04-26−2,936,283→ 0 total
Conversion
Zymergen Inc.
Series B Preferred Stock
2021-04-26−1,684,397→ 0 total
Conversion
Zymergen Inc.
Common Stock
2021-04-26+2,936,283→ 2,936,283 total
Conversion
Zymergen Inc.
Common Stock
2021-04-26+2,014,506→ 2,224,956 total
Conversion
Zymergen Inc.
Common Stock
2021-04-26+210,450→ 210,450 total
Conversion
Zymergen Inc.
Common Stock
2021-04-26+1,687,050→ 4,623,333 total
Other
RECURSION PHARMACEUTICALS, INC.$RXRX
Common Stock
2021-04-20−3,726,963→ 0 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Common Stock
2021-04-20+5,941,120→ 5,941,120 total
Other
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2021-04-20+5,941,120→ 5,941,120 total
Other
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2021-04-20+3,951,141→ 3,951,141 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Common Stock
2021-04-20+3,726,963→ 3,726,963 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Common Stock
2021-04-20+3,951,141→ 3,951,141 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Series A Preferred Stock
2021-04-20−3,771,996→ 0 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Series B Preferred Stock
2021-04-20−3,220,788→ 0 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Series C Preferred Stock
2021-04-20−1,095,529→ 0 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Series C Preferred Stock
2021-04-20−730,353→ 0 total
Other
RECURSION PHARMACEUTICALS, INC.$RXRX
Common Stock
2021-04-20−5,941,120→ 0 total
Other
RECURSION PHARMACEUTICALS, INC.$RXRX
Common Stock
2021-04-20−3,951,141→ 0 total
Other
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2021-04-20+3,726,963→ 3,726,963 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Series B Preferred Stock
2021-04-20−1,073,595→ 0 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Series D Preferred Stock
2021-04-20−3,726,963→ 0 total
Conversion
AbCellera Biologics Inc.$ABCL
Convertible Note
2020-12-15→ 0 total
Conversion
AbCellera Biologics Inc.$ABCL
Common Shares
2020-12-15+29,411→ 29,105,761 total
Conversion
AbCellera Biologics Inc.$ABCL
Common Shares
2020-12-15+29,076,350→ 29,076,350 total
Conversion
AbCellera Biologics Inc.$ABCL
Series A1 Preferred Shares
2020-12-15−2,105,264→ 0 total
Conversion
AbCellera Biologics Inc.$ABCL
Series A2 Preferred Shares
2020-12-15−802,371→ 0 total

Companies

Recent Filings

Address

270 UNIVERSITY AVENUE

PALO ALTO, CA, 94301

View on SEC.gov